Point of Care Diagnostics Market Size, Growth, Opportunities 2024-2032 | F. Hoffmann-La Roche Ltd., Abbott, EKF Diagnostics Holdings plc, Thermo Fisher Scientific Inc.

The global Point of Care Diagnostics Market size was valued at USD 30.87 billion in 2023. The market is projected to grow from USD 31.57 billion in 2024 to USD 51.19 billion by 2032, exhibiting a CAGR of 6.2% during the forecast period.

Point of care testing (POCT) is carried out near the site of patient care where treatment or care is delivered. The surging emphasis of companies on the development and introduction of products with advanced properties and technology in different testing kits, such as hematology testing kits, urinalysis testing kits, and infectious diseases testing kits, is leading to the surging demand for the product among patients and healthcare providers. This factor is bolstering the market growth

𝗗𝗶𝘀𝗰𝗼𝘃𝗲𝗿 𝗪𝗵𝗮𝘁 𝗬𝗼𝘂'𝗿𝗲 𝗠𝗶𝘀𝘀𝗶𝗻𝗴: 𝗚𝗲𝘁 𝗮 𝗙𝗿𝗲𝗲 𝗥𝗲𝗽𝗼𝗿𝘁 (𝗣𝗗𝗙) 𝗦𝗮𝗺𝗽𝗹𝗲: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/point-of-care-diagnostics-market-101072

𝗞𝗲𝘆 𝗜𝗻𝗱𝘂𝘀𝘁𝗿𝘆 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 :

• April 2024 - Abbott received the U.S. FDA clearance for its whole blood rapid test kit, i-STAT TBI cartridge, for the assessment of concussion at the patient's bedside.

𝗧𝗼𝗽 𝗖𝗼𝗺𝗽𝗮𝗻𝗶𝗲𝘀 𝗶𝗻 𝘁𝗵𝗲 𝗣𝗼𝗶𝗻𝘁 𝗼𝗳 𝗖𝗮𝗿𝗲 𝗗𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰𝘀 𝗠𝗮𝗿𝗸𝗲𝘁 :

• F. Hoffmann-La Roche Ltd. (Switzerland)
• Abbott (U.S.)
• EKF Diagnostics Holdings plc (U.K.)
• Cardinal Health, Inc. (U.S.)
• Thermo Fisher Scientific Inc. (U.S.)
• Quest Diagnostics Incorporated (U.S.)
• BD (U.S.)

𝗦𝗲𝗴𝗺𝗲𝗻𝘁𝘀 :

𝗕𝗹𝗼𝗼𝗱 𝗚𝗹𝘂𝗰𝗼𝘀𝗲 𝗠𝗼𝗻𝗶𝘁𝗼𝗿𝗶𝗻𝗴 𝗦𝗲𝗴𝗺𝗲𝗻𝘁 𝗟𝗲𝗮𝗱𝘀 𝘄𝗶𝘁𝗵 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝘃𝗲 𝗣𝗿𝗼𝗱𝘂𝗰𝘁𝘀 𝗛𝗮𝘃𝗶𝗻𝗴 𝗔𝗱𝘃𝗮𝗻𝗰𝗲𝗱 𝗙𝗲𝗮𝘁𝘂𝗿𝗲𝘀

In terms of product, the market is categorized into infectious disease testing, hematology testing, blood glucose monitoring, pregnancy & fertility testing, cardiometabolic disease testing, and others. The blood glucose monitoring segment registered the largest point of care diagnostics market share in 2023, with the rising emphasis of companies on launching and developing products with advanced technology and features.

𝗥𝗶𝘀𝗶𝗻𝗴 𝗜𝗻𝗰𝗶𝗱𝗲𝗻𝗰𝗲 𝗼𝗳 𝗗𝗶𝘀𝗼𝗿𝗱𝗲𝗿𝘀 𝗥𝗲𝗹𝗮𝘁𝗲𝗱 𝘁𝗼 𝗞𝗶𝗱𝗻𝗲𝘆 𝗙𝘂𝗻𝗰𝘁𝗶𝗼𝗻𝘀 𝘁𝗼 𝗘𝘅𝗽𝗲𝗱𝗶𝘁𝗲 𝘁𝗵𝗲 𝗨𝗿𝗶𝗻𝗲 𝗦𝗲𝗴𝗺𝗲𝗻𝘁 𝗘𝘅𝗽𝗮𝗻𝘀𝗶𝗼𝗻

On the basis of sample, the market is segregated into urine, blood, nasal and oropharyngeal swabs, and others. The urine segment is poised to expand at a significant CAGR during the forecast period on the back of the growing occurrence of disorders associated with kidney functions among the population.

𝗜𝗻𝗰𝗿𝗲𝗮𝘀𝗶𝗻𝗴 𝗨𝗽𝘁𝗮𝗸𝗲 𝗼𝗳 𝗔𝗱𝘃𝗮𝗻𝗰𝗲𝗱 𝗣𝗢𝗖 𝗧𝗲𝘀𝘁𝗶𝗻𝗴 𝗗𝗲𝘃𝗶𝗰𝗲𝘀 𝘁𝗼 𝗣𝗿𝗼𝗽𝗲𝗹 𝘁𝗵𝗲 𝗛𝗼𝘀𝗽𝗶𝘁𝗮𝗹 𝗕𝗲𝗱𝘀𝗶𝗱𝗲 𝗦𝗲𝗴𝗺𝗲𝗻𝘁 𝗘𝘅𝗽𝗮𝗻𝘀𝗶𝗼𝗻

With respect to end-user, the market is classified into urgent care & retail clinics, hospital bedside, home & self-testing, and physician's office lab. The hospital bedside segment occupied the largest share in 2023. The surging uptake of advanced POC testing devices and instruments in hospitals in developed nations is augmenting the hospital bedside segment growth.

From the regional perspective, the market for point of care diagnostics is categorized into the Asia Pacific, Latin America, North America, the Middle East & Africa, and Europe.

𝗥𝗲𝗽𝗼𝗿𝘁 𝗖𝗼𝘃𝗲𝗿𝗮𝗴𝗲 :

The report provides a comprehensive coverage of the key driving and restraining factors impacting the market growth. In addition, it offers vital insights into the key industry developments, dominating segments, and the impact of the COVID-19 pandemic on the market growth. Other aspects of the report include the strategic initiatives undertaken by leading companies to gain a competitive edge.

𝗙𝗼𝗿 𝗙𝘂𝗹𝗹 𝗥𝗲𝗽𝗼𝗿𝘁 𝗖𝗼𝘃𝗲𝗿𝗮𝗴𝗲 𝗩𝗶𝘀𝗶𝘁 : https://www.fortunebusinessinsights.com/industry-reports/point-of-care-diagnostics-market-101072

𝗗𝗿𝗶𝘃𝗲𝗿𝘀 𝗮𝗻𝗱 𝗥𝗲𝘀𝘁𝗿𝗮𝗶𝗻𝘁𝘀 :

𝗦𝘂𝗿𝗴𝗶𝗻𝗴 𝗜𝗻𝗰𝗶𝗱𝗲𝗻𝗰𝗲 𝗼𝗳 𝗖𝗵𝗿𝗼𝗻𝗶𝗰 𝗗𝗶𝘀𝗼𝗿𝗱𝗲𝗿𝘀 𝗮𝗻𝗱 𝗜𝗻𝗳𝗲𝗰𝘁𝗶𝗼𝘂𝘀 𝗗𝗶𝘀𝗲𝗮𝘀𝗲𝘀 𝘁𝗼 𝗜𝗺𝗽𝗲𝗹 𝗣𝗿𝗼𝗱𝘂𝗰𝘁 𝗗𝗲𝗺𝗮𝗻𝗱, 𝗘𝘀𝗰𝗮𝗹𝗮𝘁𝗶𝗻𝗴 𝗠𝗮𝗿𝗸𝗲𝘁 𝗚𝗿𝗼𝘄𝘁𝗵

One of the key factors driving the point of care diagnostics market growth is a rise in the occurrence of infectious diseases and chronic disorders. The 2022 WHO data reported approximately 39.0 million people living with HIV. In addition, rising incidences of chronic diseases are envisaged to propel market growth.

Despite such growth opportunities, the scarcity of accuracy of point of care tests may hamper uptake of the devices, hindering market growth.

𝗥𝗲𝗴𝗶𝗼𝗻𝗮𝗹 𝗜𝗻𝘀𝗶𝗴𝗵𝘁𝘀 :

𝗡𝗼𝗿𝘁𝗵 𝗔𝗺𝗲𝗿𝗶𝗰𝗮'𝘀 𝗗𝗼𝗺𝗶𝗻𝗮𝗻𝗰𝗲 𝗟𝗲𝗱 𝗯𝘆 𝗛𝗲𝗮𝗹𝘁𝗵𝘆 𝗙𝘂𝗻𝗱𝗶𝗻𝗴 𝗘𝗻𝘃𝗶𝗿𝗼𝗻𝗺𝗲𝗻𝘁

North America was valued at USD 10.92 billion in 2023 and is anticipated to lead during the forecast period. This can be credited to the rising funding environment coupled with the availability of supportive reimbursement policies.

Europe market for point of care diagnostics registered a notable share in 2023 due to the emphasis of prominent companies on releasing quick diagnostics tests for the time-efficient diagnosis of infectious diseases.

𝗖𝗼𝗺𝗽𝗲𝘁𝗶𝘁𝗶𝘃𝗲 𝗟𝗮𝗻𝗱𝘀𝗰𝗮𝗽𝗲 :

𝗞𝗲𝘆 𝗣𝗹𝗮𝘆𝗲𝗿𝘀 𝗟𝗲𝘃𝗲𝗿𝗮𝗴𝗲 𝗖𝗮𝗽𝗮𝗰𝗶𝘁𝘆 𝗘𝘅𝗽𝗮𝗻𝘀𝗶𝗼𝗻𝘀 𝘁𝗼 𝗘𝗻𝗵𝗮𝗻𝗰𝗲 𝗧𝗵𝗲𝗶𝗿 𝗣𝗼𝘀𝗶𝘁𝗶𝗼𝗻

The point of care diagnostics market represents a semi-consolidated structure, with a few leading companies registering a majority of market share. Abbott, Danaher Corporation, and F. Hoffmann-La Roche Ltd. are some of the leading companies with an extensive range of product portfolios. Many companies are also focusing on capacity expansions to boost their position.

𝗖𝘂𝘀𝘁𝗼𝗺𝗶𝘇𝗲 𝘁𝗵𝗶𝘀 𝗿𝗲𝗽𝗼𝗿𝘁 𝗮𝗰𝗰𝗼𝗿𝗱𝗶𝗻𝗴 𝘁𝗼 𝘆𝗼𝘂𝗿 𝗰𝗼𝗻𝘃𝗲𝗻𝗶𝗲𝗻𝗰𝗲 : https://www.fortunebusinessinsights.com/enquiry/ask-for-customization/point-of-care-diagnostics-market-101072

𝗖𝗼𝗻𝘁𝗮𝗰𝘁 𝗨𝘀:
Fortune Business Insights™ Pvt. Ltd.
9th Floor, Icon Tower,
Baner, Pune-411045,
Maharashtra, India.
Phone:
U.S.: US +1 833 909 2966 (Toll Free)
UK +44 808 502 0280 (Toll Free)
APAC +91 744 740 1245
Email: sales@fortunebusinessinsights.com

𝗔𝗯𝗼𝘂𝘁 𝗨𝘀:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

This release was published on openPR.